Drugs for Treatment of Hyperkalemia and Hyperphosphatemia

DrugDrug NameDrug Description
DB00258Calcium acetateA phosphate binder used in patients with end-stage renal disease (ESRD) to prevent elevated phosphate levels and resulting ectopic calcification and secondary hyperparathyroidism.
DB00658SevelamerA phosphate binder used to treat hyperphosphatemia.
DB01344TolevamerA potassium-binding resin used in the treatment of hyperkalemia.
DB06792Lanthanum carbonateA phosphate binder indicated for the reduction of serum phosphate in patients with end stage renal disease.
DB09146Iron sucroseAn compound used as a source of iron in patients with iron deficiency anemia associated with chronic kidney disease (CKD).
DB11634Colestilan chlorideColestilan is an ingredient in the EMA-withdrawn product BindRen.
DB09481Magnesium carbonateAn antacid used for symptomatic relief of heartburn, indigestion, and upset stomach.
DB14520Tetraferric tricitrate decahydrateA phosphate binder used to control serum phosphorus levels or as an iron supplement.
DB14048Sodium zirconium cyclosilicateA potassium binder used to treat hyperkalemia.